CCMT
BMY icon

CMT Capital Markets Trading’s Bristol-Myers Squibb BMY Stock Holding History

CMT Capital Markets Trading’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,870
Closed -$459K – 289
2024
Q3 		$459K Buy
+8,870
New +$416K 0.01% 258
2024
Q1 		– Sell
-21,992
Closed -$1.12M – 249
2023
Q4 		$1.13M Sell
21,992
-39,951
-64% -$2.1M 0.01% 194
2023
Q3 		$3.6M Buy
61,943
+53,943
+674% +$3.31M 0.05% 157
2023
Q2 		$512K Buy
+8,000
New +$536K ﹤0.01% 226
2022
Q1 		– Sell
-12,600
Closed -$846K – 305
2021
Q4 		$786K Buy
+12,600
New +$739K ﹤0.01% 292
2021
Q3 		– Sell
-16,000
Closed -$1.05M – 319
2021
Q2 		$1.07M Buy
+16,000
New +$1.04M 0.01% 241
2021
Q1 		– Sell
-171,000
Closed -$10.6M – 263
2020
Q4 		$10.6M Buy
171,000
+129,800
+315% +$7.98M 0.1% 105
2020
Q3 		$2.42M Hold
41,200
– – 0.02% 168
2020
Q2 		$2.42M Buy
+41,200
New +$2.46M 0.04% 156
2019
Q3 		– Sell
-55,931
Closed -$2.63M – 153
2019
Q2 		$2.54M Buy
55,931
+50,115
+862% +$2.33M 0.08% 93
2019
Q1 		$277K Buy
+5,816
New +$290K 0.01% 120
2018
Q4 		– Sell
-18,491
Closed -$993K – 128
2018
Q3 		$1.15M Buy
+18,491
New +$1.1M 0.03% 101
2018
Q2 		– Sell
-6,736
Closed -$364K – 155
2018
Q1 		$426K Buy
+6,736
New +$433K 0.01% 121
2017
Q4 		– Sell
-9,056
Closed -$566K – 139
2017
Q3 		$577K Buy
+9,056
New +$529K 0.02% 129
2017
Q2 		– Sell
-21,984
Closed -$1.2M – 149
2017
Q1 		$1.2M Sell
21,984
-9,179
-29% -$503K 0.12% 94
2016
Q4 		$1.82M Buy
31,163
+21,110
+210% +$1.15M 0.16% 93
2016
Q3 		$542K Buy
+10,053
New +$646K 0.05% 127
2015
Q3 		– Sell
-5,164
Closed -$328K – 134
2015
Q2 		$344K Buy
+5,164
New +$340K 0.05% 116

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CMT Capital Markets Trading's BMY Position: Q4 2024 in Review

CMT Capital Markets Trading sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 8,870 shares — an estimated $459K sold.

CMT Capital Markets Trading first reported a position in BMY in Q2 2015 and held it in 18 quarters. The position peaked at $10.6M in Q4 2020. 2,487 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • CMT Capital Markets Trading reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
  • CMT Capital Markets Trading sold 8,870 Bristol-Myers Squibb shares in Q4 2024, an estimated $459K.
  • CMT Capital Markets Trading first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 18 quarters.
  • CMT Capital Markets Trading's Bristol-Myers Squibb position peaked at $10.6M in Q4 2020.
  • 2,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on CMT Capital Markets Trading's 13F filing for Q4 2024, filed 14 Feb 2025.